Viewing StudyNCT06443944



Ignite Creation Date: 2024-06-16 @ 11:50 AM
Last Modification Date: 2024-10-26 @ 3:31 PM
Study NCT ID: NCT06443944
Status: AVAILABLE
Last Update Posted: 2024-06-05
First Post: 2024-05-30

Brief Title: An Expanded Access Program of Cretostimogene Grenadenorepvec for Treatment of NMIBC for Patients Unresponsive to BCG
Sponsor: CG Oncology Inc
Organization: CG Oncology Inc

Key Dates - Follows AllAPIJSON File Order

Start Date: None
Start Date Type: None
Primary Completion Date: None
Primary Completion Date Type: None
Completion Date: None
Completion Date Type: None
First Submit Date: 2024-05-30
First Submit QC Date: May 30 2024
Study First Post Date: 2024-06-05
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-05-30
Last Update Post Date: 2024-06-05
Last Update Post Date Type: ACTUAL